Silymarin (Legalon Forte, Legalon)
Silymarin
Shanur Healthcare (Pty) Ltd
Registration
- Applicant
- Shanur Healthcare (Pty) Ltd
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Legalon forte EACH CAPSULE CONTAINS: EXTRACT OF MILK THISTLE FRUITS EQUIVALENT TO SILYMARIN 140,0 mg | Not listed | 45113245/7.4/1132 | Registered | Not determined | None |
| Legalon 70 EACH TABLET CONTAINS :SILYMARIN 70,0 mg | 70 | R0172R/7.4/172 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Silymarin
- except when present in a complementary medicine with an accepted low risk claim or health claim, providing not more than 600 mg of Silymarin per day (calculated as silibinin/silybin). (S0)
Consolidated Schedules 06 July 2026, lines 4246 to 4247
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one
Drag to rotate. Structure from PubChem CID 5213.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.